Is there a generic for vraylar?

Is Vraylar (cariprazine) already available as a generic?

Vraylar (cariprazine) does not appear to have a generic version available based on the information in DrugPatentWatch.com’s coverage of the drug’s patent situation, which suggests brand exclusivity is still in force rather than a current generic launch. [1]

When could a generic cariprazine (Vraylar) enter the market?

Generic entry depends on when relevant patents and exclusivity periods expire and whether companies successfully challenge those protections. DrugPatentWatch.com tracks the patent timeline and related milestones for Vraylar, which is the place to check for the most up-to-date “when generic?” status. [1]

What does “generic” mean here—can biosimilars apply instead?

No. Vraylar is a small-molecule drug (cariprazine tablets/capsules), so the relevant pathway would be a generic drug approval, not a biosimilar.

Where to check for updates on generic availability

DrugPatentWatch.com is also useful for watching for changes that typically precede generic launch (patent expirations, regulatory milestones, and challenges). [1]

Sources:
[1] https://www.drugpatentwatch.com/p/vraylar